Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]

Newly diagnosed multiple myeloma: Laying a solid foundation for improved long...

Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France

Newly diagnosed multiple myeloma: Laying a solid foundation for improved long-term outcomes ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )

Neurological concerns in multiple myeloma

Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria

Neurological concerns in multiple myeloma ( Prof Wolfgang Grisold - Medical University of Vienna, Vienna, Austria )

Filtering through the options: Renal considerations in disease management

Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK

Filtering through the options: Renal considerations in disease management ( Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK )

ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory...

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA

$ADMIRAL: Gilteritinib as treatment for patients with relapsed or refractory acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )$

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone...

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA

$Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )$

Gilteritinib improved survival for patients with acute myeloid leukaemia

Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA

Gilteritinib improved survival for patients with acute myeloid leukaemia ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )

Inhibiting MDM2 to promote apoptosis in ALL

Prof Binghe Wang - Georgia State University, Atlanta, USA

Inhibiting MDM2 to promote apoptosis in ALL ( Prof Binghe Wang - Georgia State University, Atlanta, USA )

Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia

Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA

Characterisation of novel subtypes in B progenitor acute lymphoblastic leukaemia ( Dr Zhaohui Gu - St. Jude Children's Research Hospital, Memphis, USA )

Bispecific CD19/22 CAR therapy in children and young adults with ALL

Dr Liora M Schultz - Stanford University, Palo Alto, USA

Bispecific CD19/22 CAR therapy in children and young adults with ALL ( Dr Liora M Schultz - Stanford University, Palo Alto, USA )

Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent...

Dr Nicole Carreau - NYU Langone Health, New York, USA

Checkpoint blockade therapy may sensitise non-Hodgkin lymphoma to subsequent therapy ( Dr Nicole Carreau - NYU Langone Health, New York, USA )

Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone...

Dr Mark Bustoros - Harvard Medical School, Boston, USA

Phase II trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smouldering multiple myeloma ( Dr Mark Bustoros - Harvard Medical School, Boston, USA )

Indoximod combined with chemotherapy in newly diagnosed AML patients

Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA

Indoximod combined with chemotherapy in newly diagnosed AML patients ( Dr Ashkan Emadi - University of Maryland Medical Centre, Maryland, USA )

More from ecancer